Adverse drug events or unplanned hospitalizations are seldom the reason home infusion patients discontinue infusion therapy, according to recently published results from the National Home Infusion Foundation’s (NHIF) national benchmarking program.
Patients were far more likely to stop infusion service once their therapy was complete per physician orders, such as after a 14-day infusion cycle of an IV antibiotic, after which someone shows sufficient clinical response to no